At 8.9% CAGR, the Europe Non-Emergency Medical Transportation Market is projected to be worth US$ 2,714.95 million by 2028, says Business Market Insights           

According to Business Market Insights’ research, the Europe non-emergency medical transportation market was valued at US$ 1,627.96 million in 2022 and is expected to reach US$ 2,714.95 million by 2028, registering a CAGR of 8.9% from 2022 to 2028. Growing need for non-emergency medical transportation, rising incidence of chronic conditions, and increasing geriatric population are the critical factors attributed to the market expansion.                  

Since 1965, Medicaid has had a non-emergency medical transportation (NEMT) benefit and people covered by Medicaid are provided with transportation services as an essential benefit. Nearly 75 million individuals were enrolled in Medicaid till 2019. Most of the NEMT services are delivered through NEMT brokers or managed care organizations (MCOs). In many states, the brokers or MCOs receive a per capita payment to manage the NEMT, while in other states, NEMT is delivered on a fee-for-service basis through local service providers. The Children’s Health Insurance Program (CHIP) provides health coverage to eligible children through Medicaid and separate CHIP programs. CHIP is administered by states as per federal requirements, and it is funded jointly by state governments and the federal government. Thus, with an increase in such initiatives by governments, the need for NEMT is rising, thereby boosting the market growth.

On the contrary, lack of transportation services in rural areas hampers the Europe non-emergency medical transportation market. 

• Based on service type, the market is segmented into private pay patient transportation, insurance backed patient transportation, courier services, and other services. The private pay patient transportation segment held 51.16% market share in 2022, amassing US$ 832.78 million. It is projected to garner US$ 1,418.41 million by 2028 to expand at 9.3% CAGR during 2022–2028.    
• Based on application, the market is segmented into dialysis, routine doctor visits, mental health related appointments, rehabilitation, and others. The mental health related appointments segment held 38.68% market share in 2022, amassing US$ 629.64 million. It is projected to garner US$ 1,066.45 million by 2028 to expand at 9.2% CAGR during 2022–2028.
• Based on country, the Europe non-emergency medical transportation market has been categorized into Germany, France, Italy, Spain, and Rest of Europe. Our regional analysis states that Germany captured 24.12% market share in 2022. It was assessed at US$ 392.66 million in 2022 and is likely to hit US$ 674.81 million by 2028, exhibiting a CAGR of 9.1% during the forecast period.            

Key players dominating the Europe non-emergency medical transportation market are ERS Transition Ltd; GLOBAL RESCUE LLC.; London Medical Transportation Systems, and FirstGroup plc, among others.

•  In Jun 2022; MTM, Inc. launched its Elevate program to get ahead of any potential escalated trip issues. MTM deploys a proactive approach to trips for members of its Elevate Program, offering concierge-level service for complicated trips and members who have unique transportation needs. The focus of Elevate program has improved trip delivery for critical members and reduced complaints and escalated events for the company’s clients.

• In Oct 2021; FirstGroup announced the sale of Greyhound Lines to FlixMobility, completing its stated strategy to focus on its leading UK public transport businesses.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com